HMG-CoA Lyase Deficiency
Other Names
3-hydroxy-3-methylglutaryl-CoA lyase deficiency
HMG lyase deficiency
Hydroxymethylglutaric aciduria
HL deficiency
Overview
The lack of the enzyme 3-hydroxy-3-methylglutaryl-CoA lyase (usually expressed at high levels in the liver) impairs the formation of ketone bodies from fat and the break down of leucine [Puisac: 2010]. This results in increased utilization of glucose with hypoglycemia and accumulation of toxic metabolites. The lack of energy causes seizures and lethargy, accompanied by metabolic acidosis and hypoketotic hypoglycemia. Mutations in the HMGCL gene cause HMG-CoA lyase deficiency.Incidence
Rare [HMG-CoA Lyase Deficiency - Information for Professionals (STAR-G)]Prenatal Testing
DNA testing by amniocentesis or chorionic villus sampling (CVS) if both disease causing mutations of an affected family member have been identified; enzyme testing by maternal urine analysis possible at >23 weeks gestational age.Clinical Characteristics
With treatment, normal development and IQ are possible. However, severe episodes of hypoglycemia may still result in seizures and/or mental retardation. Without treatment, recurring metabolic crises, associated with illness or fasting, will likely result in developmental delay/mental retardation or death. Symptoms generally begin from infancy up to 3 years of age. Affected children may be healthy between metabolic crises.Initial signs/symptoms may include:
- Poor feeding
- Vomiting
- Irritability
- Lethargy
- Lab findings:
- Metabolic acidosis
- Non-ketotic hypoglycemia
- Failure to thrive
- Hepatomegaly
- Seizures
- Apnea
- Developmental delay/mental retardation
- Death
Follow-up Testing after Positive Screen
Quantitative plasma acylcarnitine profile and urine organic acids.Primary Care Management
Upon Notification of the + Screen
- Contact the family and evaluate the infant for poor feeding, vomiting, or lethargy.
- Provide emergency treatment/referral for symptoms hypoglycemia, metabolic acidosis, or seizures.
- To confirm the diagnosis, work with the following service(s): Newborn Screening Services (see NM providers [1]).
- For evaluation and ongoing collaborative management, consult the following service(s): Pediatric Genetics (see NM providers [4]).
If the Diagnosis is Confirmed
- Education for the family regarding signs, symptoms, and the need for urgent care when the infant becomes ill (see HMG-CoA Lyase Deficiency - Information for Parents (STAR-G) for additional information)
- Frequent, low protein, low fat, and high carbohydrate meals - avoidance of fasting
- Oral L-carnitine and cornstarch supplementation
- Bicarbonate and glucose during metabolic crisis episodes
- For those identified after irreversible consequences, assist in management, particularly with developmental and educational interventions.
Specialty Care Collaboration
Initial consultation with the following service(s):Pediatric Genetics (see NM providers [4]); and ongoing collaboration if the child is affected. A dietician may work with the family to devise an optimal approach to dietary management. Genetic counseling for the family.Resources
Information & Support
For Professionals
Resources for HMG-CoA Lyase Deficiency (Disease InfoSearch)
Compilation of information, articles, research, case studies, and genetics links; from Genetic Alliance.
HMG-CoA Lyase Deficiency (OMIM)
Information about clinical features, diagnosis, management, and molecular and population genetics; Online Mendelian Inheritance
in Man, authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
Genetics in Primary Care Institute (AAP)
Contains health supervision guidelines and other useful resources for the care of children with genetic disorders; American
Academy of Pediatrics.
For Parents and Patients
HMG-CoA Lyase Deficiency - Information for Parents (STAR-G)
A fact sheet, written by a genetic counselor and reviewed by metabolic and genetic specialists, for families who have received
an initial diagnosis of this newborn disorder; Screening, Technology and Research in Genetics.
Organic Acidemia Association (OAA)
A nonprofit organization that provides information, support, events, connections with other parents, a discussion board,
and nutrition and recipe ideas.
3-hydroxy-3-methylglutaryl-CoA lyase deficiency (MedlinePlus)
Information for families that includes description, frequency, causes, inheritance, other names, and additional resources;
from the National Library of Medicine.
Tools
3-hydroxymethylglutaryl-CoA (3-HMG CoA) Lyase Deficiency (NECMP)
A guideline for health care professionals treating the sick infant/child who has previously been diagnosed with HMG-CoA lyase
deficiency; developed under the direction of Dr. Harvey Levy, Senior Associate in Medicine/Genetics at Children’s Hospital
Boston, and Professor of Pediatrics at Harvard Medical School, for the New England Consortium of Metabolic Programs.
ACT Sheet for Elevated C5-OH Acylcarnitine (ACMG) (
400 KB)
Contains short-term recommendations for clinical follow-up of the newborn who has screened positive; American College of Medical
Genetics.
Services for Patients & Families in New Mexico (NM)
| Service Categories | # of providers* in: | NM | NW | Other states (5) (show) | | ID | MT | NV | RI | UT |
|---|---|---|---|---|---|---|---|---|---|---|
| Newborn Screening Services | 1 | 1 | 22 | 4 | 2 | 1 | 3 | |||
| Pediatric Genetics | 4 | 1 | 3 | 7 | 4 | 4 | 6 | |||
For services not listed above, browse our Services categories or search our database.
* number of provider listings may vary by how states categorize services, whether providers are listed by organization or individual, how services are organized in the state, and other factors; Nationwide (NW) providers are generally limited to web-based services, provider locator services, and organizations that serve children from across the nation.
Page Bibliography
Puisac B, Arnedo M, Casale CH, Ribate MP, Castiella T, Ramos FJ, Ribes A, Pérez-Cerdá C, Casals N, Hegardt FG, Pié J.
Differential HMG-CoA lyase expression in human tissues provides clues about 3-hydroxy-3-methylglutaric aciduria.
J Inherit Metab Dis.
2010;33(4):405-10.
PubMed abstract / Full Text
The pathophysiology of 3-Hydroxy-3-methylglutaric aciduria, caused by HMG-CoA lyase deficiency, is only partially understood.
Findings from this study help the understanding of the enzyme function and consequences of its deficiency and suggest the
need for pancreatic damage assessment.